Literature DB >> 17601785

Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis.

Guifeng Sun1, Sukumar Pal, Annahita K Sarcon, Soyoun Kim, Etsuko Sugawara, Hiroshi Nikaido, Melanie J Cocco, Ellena M Peterson, Luis M de la Maza.   

Abstract

Chlamydia trachomatis is a major pathogen throughout the world, and preventive measures have focused on the production of a vaccine using the major outer membrane protein (MOMP). Here, in elementary bodies and in preparations of the outer membrane, we identified native trimers of the MOMP. The trimers were stable under reducing conditions, although disulfide bonds appear to be present between the monomers of a trimer and between trimers. Cross-linking of the outer membrane complex demonstrated that the MOMP is most likely not in a close spatial relationship with the 60- and 12-kDa cysteine-rich proteins. Extraction of the MOMP from Chlamydia isolates under nondenaturing conditions yielded the trimeric conformation of this protein as shown by cross-linking and analysis by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis with different concentrations of acrylamide. Using circular dichroism spectroscopy, we determined that the trimers were formed mainly of beta-pleated sheet structures in detergent micelles. Using a liposomal swelling assay, the MOMP was found to have porin activity, and the size of the pore was estimated to be approximately 2 nm in diameter. The trimers were found to be stable in SDS at temperatures ranging from 4 to 37 degrees C and over a pH range of 5.0 to 8.0. In addition, the trimers of MOMP were found to be resistant to digestion with trypsin. In conclusion, these results show that the native conformation of the MOMP of C. trachomatis is a trimer with predominantly a beta-sheet structure and porin function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601785      PMCID: PMC1951919          DOI: 10.1128/JB.00552-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  73 in total

1.  DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data.

Authors:  Lee Whitmore; B A Wallace
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  Expression of porin from Rhodopseudomonas blastica in Escherichia coli inclusion bodies and folding into exact native structure.

Authors:  B Schmid; M Krömer; G E Schulz
Journal:  FEBS Lett       Date:  1996-02-26       Impact factor: 4.124

3.  Demonstration of a folded monomeric form of porin PhoE of Escherichia coli in vivo.

Authors:  P Van Gelder; J Tommassen
Journal:  J Bacteriol       Date:  1996-09       Impact factor: 3.490

4.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Characterization of porins from the outer membrane of Salmonella typhimurium. 2. Physical properties of the functional oligomeric aggregates.

Authors:  M Tokunaga; H Tokunaga; Y Okajima; T Nakae
Journal:  Eur J Biochem       Date:  1979-04

6.  Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 7.  Disulfide cross-linked envelope proteins: the functional equivalent of peptidoglycan in chlamydiae?

Authors:  T P Hatch
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

8.  Identification and characterization of porins in Pseudomonas aeruginosa.

Authors:  H Nikaido; K Nikaido; S Harayama
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

9.  Electrophoretic analysis of the major outer membrane protein of Chlamydia psittaci reveals multimers which are recognized by protective monoclonal antibodies.

Authors:  M C McCafferty; A J Herring; A A Andersen; G E Jones
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

10.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

View more
  46 in total

Review 1.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Vaccination with major outer membrane protein proteosomes elicits protection in mice against a Chlamydia respiratory challenge.

Authors:  Delia F Tifrea; Sukumar Pal; Deana N Toussi; Paola Massari; Luis M de la Maza
Journal:  Microbes Infect       Date:  2013-08-30       Impact factor: 2.700

3.  Evolutionary dynamics of ompA, the gene encoding the Chlamydia trachomatis key antigen.

Authors:  Alexandra Nunes; Maria J Borrego; Baltazar Nunes; Carlos Florindo; João P Gomes
Journal:  J Bacteriol       Date:  2009-09-25       Impact factor: 3.490

4.  Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.

Authors:  Sukumar Pal; Jose Bravo; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

5.  Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.

Authors:  Delia F Tifrea; Sukumar Pal; Jean-Luc Popot; Melanie J Cocco; Luis M de la Maza
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

6.  Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection.

Authors:  Norma Olivares-Zavaleta; William Whitmire; Donald Gardner; Harlan D Caldwell
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

7.  Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.

Authors:  Guifeng Sun; Sukumar Pal; Joseph Weiland; Ellena M Peterson; Luis M de la Maza
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

8.  Adaptive evolution of the Chlamydia trachomatis dominant antigen reveals distinct evolutionary scenarios for B- and T-cell epitopes: worldwide survey.

Authors:  Alexandra Nunes; Paulo J Nogueira; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

9.  Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.

Authors:  Delia F Tifrea; Pooja Ralli-Jain; Sukumar Pal; Luis M de la Maza
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

10.  Isolation of Chlamydia trachomatis and membrane vesicles derived from host and bacteria.

Authors:  Kyla Frohlich; Ziyu Hua; Jin Wang; Li Shen
Journal:  J Microbiol Methods       Date:  2012-08-30       Impact factor: 2.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.